Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Contribution of tumor heterogeneity in a new animal model of CNS tumors.

Chen F, Becker AJ, LoTurco JJ.

Mol Cancer Res. 2014 May;12(5):742-53. doi: 10.1158/1541-7786.MCR-13-0531. Epub 2014 Feb 5.

2.

Cell death and neuronal differentiation of glioblastoma stem-like cells induced by neurogenic transcription factors.

Guichet PO, Bieche I, Teigell M, Serguera C, Rothhut B, Rigau V, Scamps F, Ripoll C, Vacher S, Taviaux S, Chevassus H, Duffau H, Mallet J, Susini A, Joubert D, Bauchet L, Hugnot JP.

Glia. 2013 Feb;61(2):225-39. doi: 10.1002/glia.22429. Epub 2012 Oct 9.

PMID:
23047160
3.

Overview of Transgenic Glioblastoma and Oligoastrocytoma CNS Models and Their Utility in Drug Discovery.

Chen F, Becker A, LoTurco J.

Curr Protoc Pharmacol. 2016 Mar 18;72:14.37.1-12. doi: 10.1002/0471141755.ph1437s72.

PMID:
26995546
4.

Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.

Lee C, Fotovati A, Triscott J, Chen J, Venugopal C, Singhal A, Dunham C, Kerr JM, Verreault M, Yip S, Wakimoto H, Jones C, Jayanthan A, Narendran A, Singh SK, Dunn SE.

Stem Cells. 2012 Jun;30(6):1064-75. doi: 10.1002/stem.1081.

5.
6.

Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing.

Hashizume R, Gupta N, Berger MS, Banerjee A, Prados MD, Ayers-Ringler J, James CD, VandenBerg SR.

Neuro Oncol. 2010 Apr;12(4):366-76. doi: 10.1093/neuonc/nop033. Epub 2010 Jan 11.

7.

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.

Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG.

BMC Med. 2008 Jun 24;6:14. doi: 10.1186/1741-7015-6-14.

9.

[Analysis of S100beta-v-erbB transgenic rats prone to brain tumors].

Yokoo H, Tanaka Y, Nobusawa S, Nakazato Y, Ohgaki H.

Brain Nerve. 2009 Jul;61(7):765-72. Review. Japanese.

PMID:
19618853
10.

Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.

Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, Chen AJ, Perry SR, Tonon G, Chu GC, Ding Z, Stommel JM, Dunn KL, Wiedemeyer R, You MJ, Brennan C, Wang YA, Ligon KL, Wong WH, Chin L, dePinho RA.

Cold Spring Harb Symp Quant Biol. 2008;73:427-37. doi: 10.1101/sqb.2008.73.047. Epub 2009 Jan 15.

PMID:
19150964
11.

Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma.

Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO.

Cancer Res. 2001 Sep 15;61(18):6674-8.

12.

From the Cover: Neutralization of terminal differentiation in gliomagenesis.

Hu J, Ho AL, Yuan L, Hu B, Hua S, Hwang SS, Zhang J, Hu T, Zheng H, Gan B, Wu G, Wang YA, Chin L, DePinho RA.

Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14520-7. doi: 10.1073/pnas.1308610110. Epub 2013 Aug 5.

13.

GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.

Hede SM, Hansson I, Afink GB, Eriksson A, Nazarenko I, Andrae J, Genove G, Westermark B, Nistér M.

Glia. 2009 Aug 15;57(11):1143-53. doi: 10.1002/glia.20837.

PMID:
19115382
14.

Why are systemic glioblastoma metastases rare? Systemic and cerebral growth of mouse glioblastoma.

Mourad PD, Farrell L, Stamps LD, Chicoine MR, Silbergeld DL.

Surg Neurol. 2005 Jun;63(6):511-9; discussion 519.

PMID:
15936366
15.

Rhabdoid glioblastoma: case report and literature review.

He MX, Wang JJ.

Neuropathology. 2011 Aug;31(4):421-6. doi: 10.1111/j.1440-1789.2010.01166.x. Epub 2010 Nov 24. Review.

PMID:
21092062
16.

Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment.

Havrda MC, Paolella BR, Ran C, Jering KS, Wray CM, Sullivan JM, Nailor A, Hitoshi Y, Israel MA.

Cancer Res. 2014 Mar 15;74(6):1822-32. doi: 10.1158/0008-5472.CAN-13-1839. Epub 2014 Jan 14.

17.

MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors.

Lee YY, Yang YP, Huang MC, Wang ML, Yen SH, Huang PI, Chen YW, Chiou SH, Lan YT, Ma HI, Shih YH, Chen MT.

Cell Transplant. 2014;23(4-5):669-90. doi: 10.3727/096368914X678364.

PMID:
24816458
18.

Proneural genes in neocortical development.

Wilkinson G, Dennis D, Schuurmans C.

Neuroscience. 2013 Dec 3;253:256-73. doi: 10.1016/j.neuroscience.2013.08.029. Epub 2013 Aug 30. Review.

PMID:
23999125
19.

The contribution of tumor and host tissue factor expression to oncogene-driven gliomagenesis.

Magnus N, Meehan B, Garnier D, Hashemi M, Montermini L, Lee TH, Milsom C, Pawlinski R, Ohlfest J, Anderson M, Mackman N, Rak J.

Biochem Biophys Res Commun. 2014 Nov 14;454(2):262-8. Epub 2014 Oct 23.

PMID:
25450387
20.

Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.

Zhou YX, Wang JX, Feng M, Sun CM, Sun T, Chen GL, Du ZW.

J Mol Neurosci. 2012 Jul;47(3):442-7. doi: 10.1007/s12031-011-9681-5. Epub 2011 Nov 24.

PMID:
22113362
Items per page

Supplemental Content

Write to the Help Desk